Measuring informed consent capacity in an Alzheimer's disease clinical trial.

about

Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials.

P2860

Q55372537-F97A3402-B09C-4EBB-9E56-2C3110F09F3A

P2860

Measuring informed consent capacity in an Alzheimer's disease clinical trial.

Item

http://www.wikidata.org/entity/Q42656148

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Measuring informed consent capacity in an Alzheimer's disease clinical trial.

@en

Measuring informed consent capacity in an Alzheimer's disease clinical trial.

@nl

type

Item

label

Measuring informed consent capacity in an Alzheimer's disease clinical trial.

@en

Measuring informed consent capacity in an Alzheimer's disease clinical trial.

@nl

prefLabel

Measuring informed consent capacity in an Alzheimer's disease clinical trial.

@en

Measuring informed consent capacity in an Alzheimer's disease clinical trial.

@nl

P1476

Measuring informed consent capacity in an Alzheimer's disease clinical trial.

@en

P2093

Gerard D Schellenberg

http://www.w3.org/2001/XMLSchema#string

Julia E Vertrees

http://www.w3.org/2001/XMLSchema#string

Maria D Llorente

http://www.w3.org/2001/XMLSchema#string

Mary Sano

http://www.w3.org/2001/XMLSchema#string

Maurice W Dysken

http://www.w3.org/2001/XMLSchema#string

Muralidhar Pallaki

http://www.w3.org/2001/XMLSchema#string

Peter D Guarino

http://www.w3.org/2001/XMLSchema#string

Sanjay Asthana

http://www.w3.org/2001/XMLSchema#string

Susan Love

http://www.w3.org/2001/XMLSchema#string

P2860

The ethics of randomised controlled trials from the perspectives of patients, the public, and healthcare professionals

“Mini-mental state”

Use of a modified informed consent process among vulnerable patients: a descriptive study.

Cognitive impairment and PD patients' capacity to consent to research.

Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial.

Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data.

Two domains of anosognosia in Alzheimer's disease

What makes clinical research ethical?

Quality of informed consent: a new measure of understanding among research subjects.

An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

P304

258-266

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TRCI.2016.09.001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29067313

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

informed consent

P932

5651363

http://www.w3.org/2001/XMLSchema#string

Measuring informed consent capacity in an Alzheimer's disease clinical trial.

about

P2860

P2860

Measuring informed consent capacity in an Alzheimer's disease clinical trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932